Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Twist Bioscience (TWST) has reported Short term Debt for 4 consecutive years, with $9.1 million the latest figure, recorded in Q4 2021.

• In Q4 2021, Short term Debt rose 172.49% year-over-year to $9.1 million; the TTM figure through Dec 2021 stood at $9.1 million (up 172.49% YoY), while the FY2021 annual figure was $1.6 million, down 53.44% from the prior year.
• Short term Debt rose to $9.1 million in Q4 2021 per TWST's latest filing, from $1.6 million in the prior quarter.
• Across five years, Short term Debt topped out at $9.1 million in Q4 2021 and bottomed at $1.6 million in Q3 2021.
• Historically, Short term Debt has averaged $3.5 million across 4 years, with a median of $3.3 million in 2018.
• On a YoY basis, Short term Debt climbed as much as 172.49% in 2021 and fell as far as 53.44% in 2021.
• Twist Bioscience's Short term Debt stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then surged by 172.49% to $9.1 million in 2021.
• Business Quant data shows TWST's Short term Debt at $9.1 million in Q4 2021, $1.6 million in Q3 2021, and $2.4 million in Q2 2021.